In addition, a study showed that high SIRT2 expression leads to a better prognosis for elderly patients with CRC (Lee et al., 2020) due to its antitumor activity and it acting as a potential therapeutic target for CRC (Du et al., 2020). Here, SIRT2 is linked to colorectal carcinoma.